Intensity Therapeutics, Inc. IPO Indicating $5.10/Share; IPO Priced At $5/Share Of 3.9M Shares
Portfolio Pulse from Happy Mohamed
Intensity Therapeutics, a clinical-stage biotechnology company, has announced the pricing of its upsized initial public offering (IPO) of 3.9 million shares at $5.00 per share. The company has also granted the underwriters a 45-day option to purchase an additional 585,000 shares at the IPO price, less the underwriting discounts and commissions. The company's common stock is expected to begin trading on The Nasdaq Capital Market on June 30, 2023, under the ticker symbol 'INTS'. The net proceeds from the offering are expected to be approximately $16.2 million.
June 30, 2023 | 2:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Intensity Therapeutics has priced its IPO at $5.00 per share, with trading expected to begin on June 30, 2023. The net proceeds from the offering are expected to be approximately $16.2 million.
The IPO pricing and the start of trading are critical events for a company. The pricing of the IPO at $5.00 per share indicates the company's valuation at this stage. The expected net proceeds of $16.2 million will likely be used to fund the company's operations and development of its proprietary therapies. This news is highly relevant and important for investors in INTS.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100